Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFMO in New Onset Type 1 Diabetes
NCT02384889Phase 1Completed
- Sponsor
- Indiana University
- Start
- Apr 2015
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Difluoromethylornithine with Placebo (2 arms). Primary endpoint: Number of Participants with Dose Limiting Toxicities at 6 months. Started Apr 2015; status: completed.
02
Drugs
eflornithine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02384889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02384889.